Chemoimmunotherapy in urothelial cancer: concurrent or sequential?

Zengin, Zeynep B; Meza, Luis; Pal, Sumanta K; Grivas, Petros

Zengin, Zeynep B; Meza, Luis; Pal, Sumanta K; Grivas, Petros.

Afiliación

Zengin ZB; Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, 91010, USA.
Meza L; Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, 91010, USA.
Pal SK; Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, 91010, USA. Electronic address: spal@coh.org.
Grivas P; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, WA, USA.

Lancet Oncol ; 22(7): 894-896, 2021 07.

Article en En | MEDLINE | ID: mdl-34051179

Asunto(s)

Carcinoma de Células Transicionales; Neoplasias de la Vejiga Urinaria; Humanos; Inmunoterapia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google